Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Fey

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Therapeutische Umschau. Revue Therapeutique|November 5, 2010
[Lymphoma--a topic with seven seals]Martin F Fey
Therapeutische Umschau. Revue Therapeutique|October 2, 2010
[Salient clinical features of lymphoma and related lymphoproliferative disorders]Martin F Fey
The Lancet. Oncology|December 17, 2004
Clinical trial design in oncology: selection of patientsMartin F Fey
The Lancet. Oncology|July 11, 2002
Impact of the Human Genome Project on the clinical management of sporadic cancersMartin F Fey
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Recombinant proteins as therapeutic compounds in clinical oncology]Martin F Fey
Hematological Oncology|June 8, 2017
The costs of care in haematological cancers: Health economic issuesMartin F Fey
Therapeutische Umschau. Revue Therapeutique|December 3, 2014
[Today's cancer medicine: less could often be more]Martin F Fey
Future Oncology (London, England)|March 17, 2009
Tumor suppressor genes in myeloid differentiation and leukemogenesisChristian Britschgi, Martin F Fey
Lancet (London, England)|December 20, 2011
Marriage risk of cancer research fellowsMartin F Fey, Andreas Tobler
Journal of Hepatology|November 18, 2005
What is the current treatment of PTLD after liver transplantation?Jean-François Dufour, Martin F Fey
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Therapeutische Umschau. Revue Therapeutique|November 5, 2010
[Lymphoma--a topic with seven seals]Martin F Fey
Therapeutische Umschau. Revue Therapeutique|October 2, 2010
[Salient clinical features of lymphoma and related lymphoproliferative disorders]Martin F Fey
The Lancet. Oncology|December 17, 2004
Clinical trial design in oncology: selection of patientsMartin F Fey
The Lancet. Oncology|July 11, 2002
Impact of the Human Genome Project on the clinical management of sporadic cancersMartin F Fey
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Recombinant proteins as therapeutic compounds in clinical oncology]Martin F Fey
Hematological Oncology|June 8, 2017
The costs of care in haematological cancers: Health economic issuesMartin F Fey
Therapeutische Umschau. Revue Therapeutique|December 3, 2014
[Today's cancer medicine: less could often be more]Martin F Fey
Future Oncology (London, England)|March 17, 2009
Tumor suppressor genes in myeloid differentiation and leukemogenesisChristian Britschgi, Martin F Fey
Lancet (London, England)|December 20, 2011
Marriage risk of cancer research fellowsMartin F Fey, Andreas Tobler
Journal of Hepatology|November 18, 2005
What is the current treatment of PTLD after liver transplantation?Jean-François Dufour, Martin F Fey
Pageof 7